Intelligent Bioactive Extract Systems for Personalized Health and Wellness

Publication ID: 24-11857587_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Bioactive Extract Systems for Personalized Health and Wellness,” Published Technical Disclosure No. 24-11857587_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857587_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,587.

Summary of the Inventive Concept

The present inventive concept integrates bioactive extract compositions with advanced technologies such as AI, IoT, and blockchain to create personalized health and wellness systems, enabling real-time monitoring, prediction, and optimization of immune responses and health benefits.

Background and Problem Solved

The original patent disclosed bioactive extract compositions with antiviral, antibacterial, antifungal, antiprotozoal, and immune-boosting activities. However, these compositions lacked integration with modern technologies to provide personalized health benefits and real-time monitoring. The present inventive concept addresses this limitation by combining the bioactive extract compositions with AI, IoT, and blockchain technologies to create intelligent systems for personalized health and wellness.

Detailed Description of the Inventive Concept

The inventive concept comprises a bioactive extract composition, an AI module, and a data storage unit. The AI module analyzes data from various sources, including IoT networks and wearable devices, to provide personalized health recommendations. The data storage unit, secured by blockchain technology, stores and shares data related to the production, testing, and use of the bioactive extract compositions. The system enables real-time tracking of antiviral, antibacterial, antifungal, and antiprotozoal activities, and predicts optimal composition formulations. Additionally, the system can be integrated with mobile applications and wearable devices to provide personalized health benefits based on monitored vital signs.

Novelty and Inventive Step

The integration of bioactive extract compositions with AI, IoT, and blockchain technologies to create personalized health and wellness systems is novel and non-obvious compared to the original patent. The use of AI for analyzing data and providing personalized health recommendations, and the application of blockchain technology for secure data storage and sharing, are specific inventive steps that distinguish the present inventive concept from the prior art.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different AI algorithms, IoT network architectures, or blockchain platforms. Variations may also include the integration of additional technologies, such as natural language processing or computer vision, to enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the health and wellness industry, particularly in the areas of personalized medicine, preventive healthcare, and nutraceuticals. The target market includes consumers seeking personalized health benefits, healthcare providers, and pharmaceutical companies.

CPC Classifications

SectionClassGroup
A A61 A61K36/074
A A61 A61K36/185
A A61 A61K2236/333

Field of Art

Biotechnology and pharmaceutical sciences, specifically focused on medicinal fungal extracts, biological composition development, and health technology integration

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biotechnology, microbiology, or pharmaceutical sciences, possessing expertise in fungal extract preparation, biological activity screening, and emerging health technologies

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies with bioactive extract compositions represents a natural progression in personalized health monitoring. The combination of fungal extract technologies with AI, IoT, and blockchain platforms follows predictable technological convergence patterns in modern healthcare innovation. The technical elements disclosed in the PTD represent incremental improvements that leverage existing knowledge about bioactive extracts and emerging digital health platforms.

Obvious Combinations & Variations

Source Patent Element
Bioactive fungal extract composition with antiviral and antibacterial properties
PTD Variation
Adding AI-driven analysis and IoT monitoring of extract performance and health outcomes
Obviousness Reasoning
Applying computational analysis to biological systems is a known technique, and using machine learning to optimize health interventions represents a predictable technological extension
Source Patent Element
Medicinal fungal species grown on specific grains like rice and wheat
PTD Variation
Implementing blockchain tracking for extract production and composition verification
Obviousness Reasoning
Blockchain technology provides a logical solution for tracking biological material provenance, representing a standard technological improvement in traceability
Source Patent Element
Composition with potential immune-boosting activities
PTD Variation
Integrating wearable device monitoring to personalize health recommendations
Obviousness Reasoning
Connecting biological interventions with real-time physiological monitoring is a foreseeable technological convergence in personalized medicine
Source Patent Element
Ethanol-based extraction methods for fungal compounds
PTD Variation
Implementing machine learning algorithms to optimize extraction protocols
Obviousness Reasoning
Using computational methods to refine biological extraction techniques represents a standard approach in biotechnological process optimization
Source Patent Element
Medicinal fungal extract with multiple biological activities
PTD Variation
Creating a digital platform for comprehensive health data analysis and recommendation
Obviousness Reasoning
Developing integrated health technology platforms that combine biological and digital systems is a predictable technological evolution
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857587 and the published technical disclosure, a person of ordinary skill in the art would find the integration of bioactive fungal extract compositions with digital health technologies to be an obvious technological progression. The disclosed variations represent predictable combinations of known techniques in biotechnology and digital health monitoring, thereby rendering potential patent claims in this domain obvious and non-patentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,587
TitleBioactive extract